Actinium’s Multi-billion Dollar Market for Targeted Conditioning with their revolutionary Antibody Warhead Enabling (AWE) platform!
Actinium Pharmaceuticals is a clinical stage biopharmaceutical company, with an impressive Antibody Warhead Enabling (AWE) technology. The technology enables the development of breakthrough Antibody Radiation-Conjugates (ARCs), that combine the targeting ability of antibodies with the […]